Sanofi’s (SNY) PRIME is the second successful study on Dupixent for the prurigo nodularis indication.
https://www.entrepreneur.com/article/414335
#financialfreedomllc #businesstips #business #entrepreneur #businessowner #entrepreneurship #marketing #smallbusiness #businesscoach #digitalmarketing #success #entrepreneurlife #motivation #businessideas #businessgrowth #businesswoman #businessman #businessquotes #businessowners #businessstrategy #startup #businesslife #businessmindset #businessminded #entrepreneurs #businessadvice #entrepreneurmindset #marketingtips #onlinebusiness #branding